NM_000030.3(AGXT):c.77T>C (p.Leu26Pro) AND Primary hyperoxaluria, type I

Germline classification:: Pathogenic (1 submission)
Last evaluated:: Nov 27, 2014
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV000186277.10

Allele description [Variation Report for NM_000030.3(AGXT):c.77T>C (p.Leu26Pro)]

NM_000030.3(AGXT):c.77T>C (p.Leu26Pro)

Gene:

AGXT:alanine--glyoxylate aminotransferase [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

2q37.3

Genomic location:

Preferred name:

NM_000030.3(AGXT):c.77T>C (p.Leu26Pro)

HGVS:

NC_000002.12:g.240868942T>C
NG_008005.1:g.5198T>C
NM_000030.3:c.77T>CMANE SELECT
NP_000021.1:p.Leu26Pro
NC_000002.11:g.241808359T>C
NM_000030.2:c.77T>C

Protein change:

L26P

Links:

dbSNP: rs180177268

NCBI 1000 Genomes Browser:

rs180177268

Molecular consequence:

NM_000030.3:c.77T>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:: Primary hyperoxaluria, type I (HP1)
Synonyms:: OXALOSIS I; Primary hyperoxaluria type 1; Oxalosis 1; See all synonyms [MedGen]
Identifiers:: MONDO: MONDO:0009823; MedGen: C0268164; Orphanet: 416; Orphanet: 93598; OMIM: 259900

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV000239602	Clinical Biochemistry Laboratory, Health Services Laboratory	no assertion criteria provided	Pathogenic (Nov 27, 2014)	germline	in vitro	PubMed (1) [See all records that cite this PMID] Citation Link

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV000239602

Clinical Biochemistry Laboratory, Health Services Laboratory

no assertion criteria provided

Pathogenic
(Nov 27, 2014)

germline

in vitro

PubMed (1)
[See all records that cite this PMID]

Citation Link

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	yes	not provided	not provided	not provided	not provided	not provided	in vitro

Citations

PubMed

Comprehensive mutation screening in 55 probands with type 1 primary hyperoxaluria shows feasibility of a gene-based diagnosis.

Monico CG, Rossetti S, Schwanz HA, Olson JB, Lundquist PA, Dawson DB, Harris PC, Milliner DS.

J Am Soc Nephrol. 2007 Jun;18(6):1905-14. Epub 2007 Apr 25.

PubMed [citation]

PMID:: 17460142

Details of each submission

From Clinical Biochemistry Laboratory, Health Services Laboratory, SCV000239602.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	in vitro	PubMed (1)

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	yes	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Nov 3, 2024

ClinVar

Relating variation to medicine